There are numerous reasons to hasten the introduction of new and improved contraceptives--from health concerns about the pill to the continuing medical liability crisis. Yet, U.S. organizations are far from taking a leadership position in funding, researching, and introducing new contraceptives--in fact, the United States lags behind Europe and even some developing countries in this field. Why is research and development of contraceptives stagnating? What must the nation do to energize this critical arena?
This book presents an overall examination of contraceptive development in the United States--covering research, funding, regulation, product liability, and the effect of public opinion. The distinguished authoring committee presents a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public.
The highly readable and well-organized volume will quickly become basic reading for legislators, government agencies, the pharmaceutical industry, private organizations, legal professionals, and researchers--everyone concerned about family planning, reproductive health, and the impact of the liability and regulatory systems on scientific innovations.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Committee on Contraceptive Development, National Research Council and Institute of Medicine
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Zustand: As New. Unread book in perfect condition. Artikel-Nr. 6525758
Anzahl: 1 verfügbar
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Zustand: New. Artikel-Nr. 6525758-n
Anzahl: 1 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Paperback. Zustand: Brand New. 212 pages. 9.00x6.00x9.00 inches. In Stock. Artikel-Nr. x-0309083524
Anzahl: 1 verfügbar
Anbieter: AussieBookSeller, Truganina, VIC, Australien
Paperback. Zustand: new. Paperback. There are numerous reasons to hasten the introduction of new and improved contraceptives--from health concerns about the pill to the continuing medical liability crisis. Yet, U.S. organizations are far from taking a leadership position in funding, researching, and introducing new contraceptives--in fact, the United States lags behind Europe and even some developing countries in this field. Why is research and development of contraceptives stagnating? What must the nation do to energize this critical arena? This book presents an overall examination of contraceptive development in the United States--covering research, funding, regulation, product liability, and the effect of public opinion. The distinguished authoring committee presents a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public.The highly readable and well-organized volume will quickly become basic reading for legislators, government agencies, the pharmaceutical industry, private organizations, legal professionals, and researchers--everyone concerned about family planning, reproductive health, and the impact of the liability and regulatory systems on scientific innovations. Presents an examination of contraceptive development in the United States, covering research, funding, regulation, product liability, and the effect of public opinion. This book provides a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. Artikel-Nr. 9780309083522
Anzahl: 1 verfügbar
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Artikel-Nr. GB-9780309083522
Anzahl: 1 verfügbar
Anbieter: PBShop.store US, Wood Dale, IL, USA
PAP. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Artikel-Nr. GB-9780309083522
Anbieter: Speedyhen, Hertfordshire, Vereinigtes Königreich
Zustand: NEW. Artikel-Nr. NW9780309083522
Anzahl: 1 verfügbar
Anbieter: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irland
Zustand: New. Presents an examination of contraceptive development in the United States, covering research, funding, regulation, product liability, and the effect of public opinion. This book provides a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public. Num Pages: 212 pages. BIC Classification: KNDP; MBNH4. Category: (P) Professional & Vocational. Dimension: 229 x 152. . . 1990. Revised ed. paperback. . . . . Artikel-Nr. V9780309083522
Anzahl: 10 verfügbar
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In English. Artikel-Nr. ria9780309083522_new
Anzahl: 1 verfügbar
Anbieter: Rarewaves.com USA, London, LONDO, Vereinigtes Königreich
Paperback. Zustand: New. There are numerous reasons to hasten the introduction of new and improved contraceptives--from health concerns about the pill to the continuing medical liability crisis. Yet, U.S. organizations are far from taking a leadership position in funding, researching, and introducing new contraceptives--in fact, the United States lags behind Europe and even some developing countries in this field. Why is research and development of contraceptives stagnating? What must the nation do to energize this critical arena? This book presents an overall examination of contraceptive development in the United States--covering research, funding, regulation, product liability, and the effect of public opinion. The distinguished authoring committee presents a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public.The highly readable and well-organized volume will quickly become basic reading for legislators, government agencies, the pharmaceutical industry, private organizations, legal professionals, and researchers--everyone concerned about family planning, reproductive health, and the impact of the liability and regulatory systems on scientific innovations. Artikel-Nr. LU-9780309083522
Anzahl: 1 verfügbar